SEC 13F Intelligence

Groupama Asset Managment / VRTX

Groupama Asset Managment’s Vertex Pharmaceuticals Inc Position

Does Groupama Asset Managment own Vertex Pharmaceuticals Inc (VRTX)? Yes — 165.9K shares worth $74M (+1.08% of its 13F portfolio) as of Q1 2026, up from 163.1K shares the prior filed quarter.

Position Value
$74M
Q1 2026
Shares
165.9K
% of Portfolio
+1.08%
Quarters Held
9
currently held

Position History VRTX

Reported value by quarter
Q4 ’23: $10MQ4 ’23Q1 ’24: $12MQ2 ’24: $14MQ2 ’24Q3 ’24: $13MQ4 ’24: $17MQ4 ’24Q1 ’25: $26MQ2 ’25: $27MQ2 ’25Q4 ’25: $74MQ1 ’26: $74MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026165.9K$74M+1.08%
Q4 2025163.1K$74M+1.08%
Q2 202561.3K$27M+0.45%
Q1 202551.9K$26M+0.51%
Q4 202443.5K$17M+0.35%
Q3 202434.3K$13M+0.33%
Q2 202430.6K$14M+0.19%
Q1 202410.6K$12M+0.22%
Q4 202325.0K$10M+0.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Groupama Asset Managment’s full portfolio or all institutional holders of VRTX.